370 POSTER Once weekly rIL-21 in combination with cetuximab as 1st line therpay in CRC. A dose finding safety trial
J. Cassidy, A. Anthony, B. Esmarck, E. Ehrnrooth, P. Kristjansen, A. Nihlen, L.T. Hansen, M. SaundersVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72304-8
File:
PDF, 77 KB
english, 2008